Rules concerning safety and efficacy of drugs, etc. eased

Published: 2003-01-14 07:00:00
Updated: 2003-01-14 07:00:00
The Korea Food and Drug Administration announced it would draft a revision on rules concerning safety and efficacy of drugs, etc., the salient points of which are as follows:

- The license procedures for new antineoplastic agents will be further simplified in a bid to allow them to be rapidly ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.